By Professor Andrew David Carr

Journal articles

Carr A; Boyle MJ, 1996, 'Primary HIV infection', MEDICAL JOURNAL OF AUSTRALIA, 164, pp. 105 - 106, http://dx.doi.org/10.5694/j.1326-5377.1996.tb101365.x

Cooper DA; Merigan TC, 1996, 'Clinical treatment.', AIDS (London, England), 10 Suppl A, http://dx.doi.org/10.1097/00002030-199601001-00018

Coyle P; Carr AD; Depczynski BB; Chisholm DJ, 1996, 'Diabetes mellitus associated with pentamidine use in HIV-infected patients.', The Medical journal of Australia, 165, pp. 587 - 588, http://dx.doi.org/10.5694/j.1326-5377.1996.tb138654.x

Carr A; Roseingrave P; Fitzgerald MX, 1996, 'Factors associated with stress responses in staff caring for patients with cystic fibrosis', Irish Journal of Psychology, 17, pp. 241 - 250, http://dx.doi.org/10.1080/3033910.1996.10558105

Carr A; Boyle MJ, 1996, 'Managing HIV: 2.1 Primary HIV infection', Medical Journal of Australia, 164, pp. 105 - 106, http://dx.doi.org/10.5694/j.1326-5377.1996.tb101365.x

Carr AD; Vella S; Dejong MD; Sorice F; Imrie A; Boucher CA; Cooper DA, 1996, 'A controller trial of nevirapine plus zidovudine versis zidovudine aklone in p24 antigenaemic HIV infected patients', AIDS, 10, pp. 635 - 641

Kelleher AD; Carr AD; Zaunders J; Cooper DA, 1996, 'Alterations in the immune response of HIV-infected subjects treated with an HIV specific protease inhibitor, ritonavir', Journal of Infectious Diseases, 173, pp. 321 - 329

Carr AD; Emery S; Kelleher AD; Law MG; Cooper DA, 1996, 'CD8+ lymphocyte responses to antiretroviral therapy of HIV infection', Journal of acquired immune deficiency syndrome and human retrovirology, 13, pp. 320 - 326

Carr AD; Cooper DA, 1996, 'Current clinical experience with nevirapine for HIV infection', Advances in Experimental Medicine and Biology, pp. 299 - 304

Zhu T; Wang N; Carr AD; Nam DS; Moor-Jankowski R; Cooper DA; Ho DD, 1996, 'Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions:evidence for viral compartmentalisation and selection during sexual transmission', Journal of Virology, pp. 3098 - 3107

Carr AD; Cooper DA, 1996, 'HIV protease inhibitors', AIDS, 10, pp. 151 - 157

Imrie A; Carr A; Duncombe C; Finlayson R; Vizzard J; Law M; Kaldor J; Penny R; Cooper DA, 1996, 'Primary infection with zidovudine-resistant human immunodeficiency virus type 1 does not adversely affect outcome at 1 year. Sydney Primary HIV Infection Study Group.', J Infect Dis, 174, pp. 195 - 198, http://dx.doi.org/10.1093/infdis/174.1.195

Danner SA; Carr A; Leonard JM; Lehman LM; Gudiol F; Gonzales J; Raventos A; Rubio R; Bouza E; Pintado V; Aguado AG; Garcia de Lomas J; Delgado R; Borleffs JCC; Hsu A; Valdes JM; Boucher CAB; Cooper DA, 1995, 'A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of hiv-1 protease', New England Journal of Medicine, 333, pp. 1528 - 1534, http://dx.doi.org/10.1056/NEJM199512073332303

ZHU TF; WANG N; NAM DS; CAO YZ; CARR A; COOPER D; HO DD, 1995, 'PREFERENTIAL TRANSMISSION OF CELL-ASSOCIATED VIRUS AND EVIDENCE FOR SELECTION OF HIV-1 IN THE NEW HOST FOLLOWING SEXUAL CONTACT', JOURNAL OF CELLULAR BIOCHEMISTRY, pp. 230 - 230, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1995QT86500787&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Zhu T; Wang N; Carr A; Wolinsky S; Ho DD, 1995, 'Evidence for coinfection by multiple strains of human immunodeficiency virus type 1 subtype B in an acute seroconvertor', Journal of Virology, 69, pp. 1324 - 1327, http://dx.doi.org/10.1128/jvi.69.2.1324-1327.1995

Emery S; Carr A; Cooper DA, 1995, 'If it's the virus, why aren't we measuring it?', The Medical journal of Australia, 163, pp. 508 - 509, http://dx.doi.org/10.5694/j.1326-5377.1995.tb124712.x

Carr A; Cooper DA, 1995, 'Pathogenesis and management of HIV-associated drug hypersensitivity.', AIDS clinical review, pp. 65 - 97

Danner SA; Carr A; Leonard JM; Lehman LM; Gudiol F; Gonzales J; Raventos A; Rubio R; Bouza E; Pintado V; Aguado AG; Delgado R; Borleffs JCC; Hsu A; Valdes JM; Boucher CAB; Cooper DA, 1995, 'Safety, pharmacokinetics, and antiviral activity of ritonavir, an inhibitor of HIV-1 protease', JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 10, pp. 75 - 75, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1995UC13800076&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kinloch-De Loes S; Hirschel B; Hoen B; Cooper DA; Tindall B; Carr AD; Saurat JH; Clumeck N; Lazzarin A; Mathiesen L; Raffi F; Antunes F; Von Overbeck J; Luthy R; Glauser M; Hawkins D; Baumberger C; Yerly S; Perneger TV; Perrin L, 1995, 'A controlled trial of zidovudine in primary human immunodeficiency virus infection', New England Journal of Medicine, pp. 408 - 413

Zaunders J; Carr AD; Mcnally L; Penny R; Cooper DA, 1995, 'Effects of primary HIV-1 infection on subsets of CD4+ and CD8+ T lymphocytes', AIDS, pp. 561 - 566

Carr A; Gross AS; Hoskins JM; Penny R; Cooper DA, 1994, 'Acetylation phenotype and cutaneous hypersensitivity to trimethoprim-sulphamethoxazole in HIV-infected patients', AIDS, 8, pp. 333 - 337, http://dx.doi.org/10.1097/00002030-199403000-00006

Carr A; Vasak E; Munro V; Penny R; Cooper DA, 1994, 'Immunohistological assessment of cutaneous drug hypersensitivity in patients with HIV infection', Clinical and Experimental Immunology, 97, pp. 260 - 265, http://dx.doi.org/10.1111/j.1365-2249.1994.tb06078.x

Carr A; Cooper DA, 1994, 'In HIV‐infected individuals who desire combination antiviral therapy, zidovudine plus zalcitabine is preferred to zidovudine plus didanosine', Reviews in Medical Virology, 4, pp. 5 - 8, http://dx.doi.org/10.1002/rmv.1980040104

Tindall B; Carr A; Goldstein D; Penny R; Cooper DA, 1993, 'Administration of zidovudine during primary HIV-1 infection may be associated with a less vigorous immune response [1]', AIDS, 7, pp. 127 - 128, http://dx.doi.org/10.1097/00002030-199301000-00020

Carr A; Penny R; Cooper DA, 1993, 'Allergy and desensitization to zidovudine in patients with acquired immunodeficency syndrome (AIDS)', The Journal of Allergy and Clinical Immunology, 91, pp. 683 - 685, http://dx.doi.org/10.1016/0091-6749(93)90276-L

Tindall B; Forde S; Carr A; Barker S; Cooper DA, 1993, 'Attitudes to euthanasia and assisted suicide in a group of homosexual men with advanced HIV disease', Journal of Acquired Immune Deficiency Syndromes, 6, pp. 1069 - 1070

Tindall B; Elford J; Sharkey T; Carr A; Kaldor J; Cooper DA, 1993, 'CD4+ lymphocytopenia in HIV-seronegative homosexual men [4]', AIDS, 7, pp. 1272 - 1273

Carr A; Swanson C; Penny R; Cooper DA, 1993, 'Clinical and laboratory markers of hypersensitivity to trimethoprim-sulfamethoxazole in patients with pneumocystis carinii pneumonia and AIDS', Journal of Infectious Diseases, 167, pp. 180 - 185, http://dx.doi.org/10.1093/infdis/167.1.180

Caumes E; Lheriteau F; Gentilini M; Carr A; Tindall B; Cooper DA, 1993, 'Cotrimoxazole prophylaxis for toxoplasmosis [3]', Annals of Internal Medicine, 118, pp. 395, http://dx.doi.org/10.7326/0003-4819-118-5-199303010-00018

Carr A; Penny R; Cooper DA, 1993, 'Efficacy and safety of rechallenge with low-dose trimethoprim-sulphamethoxazole in previously hypersensitive HIV-infected patients', AIDS, 7, pp. 65 - 71

Carr A; Tindall B; Penny R; Cooper DA, 1993, 'In vitro cytotoxicity as a marker of hypersensitivity to sulphamethoxazole in patients with HIV', Clinical and Experimental Immunology, 94, pp. 21 - 25, http://dx.doi.org/10.1111/j.1365-2249.1993.tb05971.x

Carr A; Tindall B; Penny R; Cooper DA, 1993, 'Patterns of multiple-drug hypersensitivities in HIV-infected patients [4]', AIDS, 7, pp. 1532 - 1533, http://dx.doi.org/10.1097/00002030-199311000-00023

Carr A; Penny R; Cooper DA, 1993, 'Prophylaxis of opportunistic infections in patients with HIV infection', Journal of Acquired Immune Deficiency Syndromes, 6, pp. S56 - S60

Virus I; Masur H; Feinberg J; Bozzette SA; De Gruttola V; Edlin B; Eisinger R; El-Sadr W; Ellenberg S; Feigal D; Frame P; Goldberger M; Hafner R; Hardy WD; Harrington M; Hughes W; Kerkering T; Kovacs J; Leoung G; Montaner J; Muñoz A; Phair J; Sattler F; Spector S; Allen JR; Carr A; Chaisson R; Freedberg K; McKay J; Polis M, 1993, 'Recommendations for prophylaxis against pneumocystis carinii pneumonia for persons infected with human', Journal of Acquired Immune Deficiency Syndromes, 6, pp. 46 - 55

Carr A; Loewenthal M; Cooper DA, 1993, 'Update on reverse transcriptase inhibitors in HIV disease', Israel Journal of Medical Sciences, 29, pp. 26 - 30

Carr A; Tindall B; Brew BJ; Marriott DJ; Harkness JL; Penny R; Cooper DA, 1992, 'Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS', Annals of Internal Medicine, 117, pp. 106 - 111

Carr A; Tindall B; Penny R; Cooper DA, 1992, 'Trimethoprim-sulphamethoxazole appears more effective than aerosolized pentamidine as secondary prophylaxis against Pneumocystis carinii pneumonia in patients with AIDS', AIDS, 6, pp. 165 - 171

Carr A; Cooper DA; Penny R, 1991, 'Allergic manifestations of human immunodeficiency virus (HIV) infection', Journal of Clinical Immunology, 11, pp. 55 - 64, http://dx.doi.org/10.1007/BF00917741

Carr A, 1990, 'Drug hypersensitivity', Medical Journal of Australia, 153, pp. 631, http://dx.doi.org/10.5694/j.1326-5377.1990.tb126299.x

Back to profile page